Abstract
• Background: To improve the anatomic success rate in the surgery of full-thickness macular holes, we tested, in a prospective pilot study, the effects of autologous platelet concentrate deposited on the macula at the end of surgery. • Methods: Two consecutive groups of patients were compared. Twenty eyes (group 1, mean symptom duration 11 months) were operated on with injection of an autologous platelet concentrate on the macula after fluid-gas exchange. Another 20 eyes (group 2, mean symptom duration 11 months) were subsequently operated on without autologous platelet concentrate. For all stage 3 holes, posterior hyaloid was detached en bloc at the level of the optic disc. The patient was left supine for 24 h after surgery, and then remained face down for 10 days. • Results: In group 1, 19 cases were an anatomic success, i.e. there was flattening of the retina surrounding the hole and reattachment of the edge of the hole to the retinal pigment epithelium; in 9 cases the hole was even undetectable. Final visual acuity was 0.5 or more in 9 eyes, and 0.4 or more in 14. Visual acuity improved by two lines or more in 17 of the 19 successfully operated eyes. In group 2, only 13 cases were an anatomic success. The functional results for the successfully operated eyes were identical to those of group 1. • Conclusion: These results strongly suggested that autologous platelet concentrate could significantly improve the success rate in macular hole surgery and led us to begin a comparative, prospective, randomized trial.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Acosta F, Lashkari K, Reynaud X, Jalkh AE, Van De Velde F, Chedid N (1991) Characterization of functional changes in macular holes and cysts. Ophthalmology 98:1820–1823
Blumenkranz MS, Coll GE, Chang S, Morse LS (1994) Use of autologous plasma-thrombin mixture as adjuvant therapy for macular hole. Ophthalmology 101 [Suppl]:769
Coleman K, Hair D, Cleary PE, Collins K, Shanahan F (1994) Treatment of macular hole. Communication to Club Jules Gonin, Versailles, September
Funata M, Wendel RT, De La Cruz Z, Green WR (1992) Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 12:289–298
Garcia-Arumi J, Corcostegui B, Mateo C, Adan A, Salvador F (1994) Surgical management of idiopathic macular holes by vitrectomy and autologous serum. Communication to Club Jules Gonin, Versailles, September
Gass JDM (1988) Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 106:629–639
Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA (1992) Transforming growth factorbeta 2 for the treatment of full-thickness macular holes. Ophthalmology 99:1162–1173
Guez JE, Le Gargasson JF, Goberville M, Rigaudiere F, Massin P, Gaudric A, Grall Y (1994) Differential diagnosis of full thickness and pseudo macular holes with an SLO. Invest Ophthalmol Vis Sci 35:2135
Hitaizumi Y, Transfeldt EE, Kawahara N, Sung JH, Knighton D, Fiegel VD (1993) In vitro angiogenesis by platelet-derived wound-healing formula in injured spinal cord. Brain Res Bull 30:353–357
Johnson RN, Gass JDM (1988) Idiopathic macular holes. Observations, stages of formation and implications for surgical intervention. Ophthalmology 95:917–924
Kelly NE, Wendel RT (1991) Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 109:654–659
Ksander GA, Sawamura S, Ogawa Y, Sundsmo J, McPherson J (1990) The effect of platelet releasate on wound healing in animal models. J Am Acad Dermatol 22:781–791
Le Gargasson JF, Guez JE, Goverville M, Rigaudiere F, Massin P, Gaudric A, Grall Y (1994) Anatomical and functional examination of full thickness macular holes with an SLO. Invest Ophthalmol Vis Sci 35:2136
Le Gargasson JF, Rigaudiere F, Guez JE, Gaudric A, Grall Y (1994) Contribution of Scanning Laser Ophthalmoscope (SLO) to the functional investigation of subjects with a macular hole. Doe Ophthalmol 86:227–238
Liggett PE, Horio B, Skolik SA, Alfaro DV, Christmas NJ, Saito Y, Mieler WF (1994) Use of autologous serum in vitrectomy for full thickness macular holes. Invest Ophthalmol Vis Sci 35:1579
Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green R (1994) Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 101:682–686
Mein CE, Flynn HW (1991) Recognition and removal of the posterior cortical vitreous during vitreoretinal surgery for impending macular hole. Am J Ophthalmol 11:611–613
Patel AC, Wendel RT (1994) Vitrectomy for macular hole. Semin Ophthalmol 9:47–55
Ruby AJ, Williams DF, Grand MG, Thomas MA, Meredith TA, Boniuk I, Olk RJ (1994) Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 112:359–364
Sjaarda RN, Franck DA, Glaser BM, Thompson JT, Murphy RP (1993) Assessment of vision in idiopathic macular holes with macular microperimetry using the scanning laser ophthalmoscope. Ophthalmology 100:1513–1518
Smiddy WE, Glaser BM, Thompson JT, Sjaarda RN, Flynn HW, Hanham A, Murphy RP (1993) Tranforming growth factor-β2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Retina 13:296–301
Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW (1992) Randomized prospective double-blind trial in treating chronic diabetic foot ulcers CT 102 activated platelet supernatant, topical versus placebo. Diabetes Care 15:1598–1604
Tilanus M, Deutman AF (1994) Treatment of macular holes with Tissucol. Communication to Club Jules Gonin, Versailles, September
Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD (1993) Vitreous surgery for macular holes. Ophthalmology 100:1671–1676
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaudric, A., Massin, P., Paques, M. et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefe's Arch Clin Exp Ophthalmol 233, 549–554 (1995). https://doi.org/10.1007/BF00404704
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00404704